Development of multiple myeloma in a patient with chronic hepatitis C: A case report and review of the literature

World Journal of Gastroenterology

Volumn 12, Issue 14, 2006, Pages 2297-2300

  Lakatos, Peter Laszlo ^a   Fekete, Sandor ^b   Horanyi, Margit ^c   Fischer, Simon ^a   Abonyi, Margit E ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Szent Laszlo Hospital   (Hungary)

^c OGYK   (Hungary)

Author keywords

Extrahepatic manifestation; HCV; Multiple myeloma; Non Hodgkin Lymphoma

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; DEXAMETHASONE; DOXORUBICIN; IMMUNOGLOBULIN KAPPA CHAIN; INTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN; THALIDOMIDE; VINCRISTINE; VIRUS RNA;

ABDOMINAL MASS; ADULT; ARTICLE; BACKACHE; BONE MARROW BIOPSY; CANCER REGRESSION; CASE REPORT; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FUNCTION TEST; LUMBAR VERTEBRA; MULTIPLE MYELOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CELL; RELAPSE; VERTEBRA FRACTURE; VIRUS LOAD;

EID: 33646240333     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i14.2297     Document Type: Article

References (23)

1. Agnello V, De Rosa FG. Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol 2004; 40: 341-352
2. Gharagozloo S, Khoshnoodi J, Shokri F. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia, multiple myeloma and chronic lymphocytic leukemia. Pathol Oncol Res 2001; 7: 135-139
3. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-1495
4. Germanidis G, haioun C, Dhumeaux D, Reyes F, Pawlotsky JM. Hepatitis C virus infection, mixed cryoglobulinemia, and B-cell non-Hodgkin's lymphoma. Hepatology 1999; 30: 822-823
5. Trejo O, Ramos-Casals M, Lopez-Guillermo A, Garcia-Carrasco M, Yague J, Cervera R, Font J, Ingelmo M. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases. Semin Arthritis Rheum 2003; 33: 19-28
6. Mizorogi F, Hiramoto J, Nozato A, Takekuma Y, Nagayama K, Tanaka T, Takagi K. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma. Intern Med 2000; 39: 112-117
7. Gasztonyi B, Par A, Szomor A, Nagy A, Kereskai L, Losonczy H, Pajor L, Horanyi M, Mozsik G. Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma. Orv Hetil 2000; 141: 2649-2651
8. Rabkin CS, Tess BH, Christianson RE, Wright WE, Waters DJ, Alter HJ, Van Den Berg BJ. Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 2002; 99: 4240-4242
9. De Vita S, Zagonel V, Russo A, Rupolo M, Cannizzaro R, Chiara G, Boiocchi M, Carbone A, Franceschi S. Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma. Br J Cancer 1998; 77: 2032-2035
10. Montella M, Crispo A, Russo F, Ronga D, Tridente V, Tamburini M. Hepatitis C virus infection and new association with extrahepatic disease: multiple myeloma. Haematologica 2000; 85: 883-884
11. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-965
12. McHutchison JG, Manns M, Patel K, Poynard T, Lindsay KL, Trepo C, Dienstag J, Lee WM, Mak C, Garaud JJ, Albrecht JK. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 2002; 123: 1061-1069
13. Abonyi ME, Lakatos PL. Ribavirin in the treatment of hepatitis C. Anticancer Res 2005; 25: 1315-1320
14. Cenci M, De Soccio G, Recchia O. Prevalence of hepatitis C virus (HCV) genotypes in central Italy. Anticancer Res 2003; 23: 5129-5132
15. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, Russo D, Falasca E, Botta GA, Baccarani M. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296-4301
16. Kashyap A, Nademanee A, Molina A. Hepatitis C and B-cell lymphoma. Ann Intern Med 1998; 128: 695
17. Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G, Gentilini P, Bombardieri S, Zignego AL. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993; 82: 3701-3704
18. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. Binding of hepatitis C virus to CD81. Science 1998; 282: 938-941
19. Zignego AL, Giannelli F, Marrocchi ME, Mazzocca A, Ferri C, Giannini C, Monti M, Caini P, Villa GL, Laffi G, Gentilini P. T(14;18) translocation in chronic hepatitis C virus infection. Hepatology 2000; 31: 474-479
20. Tai DI, Tsai SL, Chen YM, Chuang YL, Peng CY, Sheen IS, Yeh CT, Chang KS, Huang SN, Kuo GC, Liaw YF. Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 2000; 31: 656-664
21. Gasztonyi B, Par A, Kiss K, Kereskai L, Szomor A, Szeberenyi J, Pajor L, Mozsik G. Activation of the nuclear factor kappa B--key role in oncogenesis? Chronic hepatitis C virus infection and lymphomagenesis. Orv Hetil 2003; 144: 863-868
22. Neri A, Fracchiolla NS, Migliazza A, Trecca D, Lombardi L. The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies. Leuk Lymphoma 1996; 23: 43-48
23. Ellis M, Rathaus M, Amiel A, Manor Y, Klein A, Lishner M. Monoclonal lymphocyte proliferation and bcl-2 rearrangement in essential mixed cryoglobulinemia. Eur J Clin Invest 1995; 25: 833-837